Thread by @TumorBoardTues

#TumorBoardTuesday

🎓We have had some highly educational🗣️on tumor biomarkers
👍This week’s conversation will NOT disappoint

📢Join us as @Latinamd & @GDutcherMD from @SylvesterCancer discuss MET Exon 14 skip mutations in #NSCLC #Miami

#TumorBoardTuesday

@Latinamd & @GDutcherMD @TumorBoardTues 🗣️
📅Tuesday, 05/24/22 at🕗8PM ET
📊✅the polls
⚖️in & bring citations🧾
🔁Retweet & tag your🩺colleagues
🏆Earn your🆓CME and MOC integrityce.com/tbt

And B4⃣the case:
🧐tell us where you are in your🩺journey
👇

#TumorBoardTuesday

#PreTest Q 1⃣ #CME
Free CME 🔗: integrityce.com/tbt

🤔Before @Latinamd & @GDutcherMD🚶us through a case of MET Exon 14 skip mutations in #NSCLC, test your🧠with these 4 quick❓

How common are METex14-skipping mutations in Non-Small Cell Lung Cancer❓

#TumorBoardTuesday

#PreTest Q 2️⃣ #CME
Free CME 🔗: integrityce.com/tbt

Which of the following is the most sensitive testing assay for detection of METex14-skipping mutations❓

#TumorBoardTuesday

#PreTest Q3⃣#CME
Free CME 🔗: integrityce.com/tbt

Which lung cancer histologies are MORE likely to present with a met-exon 14 skipping mutations❓

#TumorBoardTuesday

#PreTest Q4⃣#CME
Free CME 🔗: integrityce.com/tbt

Which treatments are FDA approved for METex14-skipping mutations❓